Post Time: 2026-03-17
The Numbers Don't Lie: My rhode Deep Dive
I pulled up the PubMed search results at 11:47 PM on a Tuesday, which is pretty standard for me. My Oura ring had already logged my sleep score (74, disappointing), my heart rate variability (52ms, acceptable), and my resting heart rate (58bpm, solid). What it couldn't tell me was whether this new thing everyone's losing their minds over—rhode—was worth the hype. So I did what I always do: I went straight to the data.
The search returned 847 papers mentioning "rhode" in some capacity. I filtered for peer-reviewed, human trials, English language, and anything published within the last five years. That dropped it to 23 papers. Not overwhelming. Let me explain what that means.
According to the research, rhode has been studied primarily in small sample sizes—most trials had fewer than 100 participants. I'm not going to pretend that's disqualifying on its face. Plenty of legitimate interventions start with small studies. But when I see a compound getting this much marketing buzz with this little clinical evidence, I get suspicious. My Notion database has tracked every supplement I've taken since 2019, and I've learned one thing: the gap between anecdotal enthusiasm and actual evidence is usually a canyon, not a crack.
I should be clear about my stance here. I'm not approaching this as someone who wants rhode to fail. I want it to work. I've spent thousands on supplements, nootropics, and biohacking tools that promised everything and delivered little. The Oura ring cost me $300. Quarterly bloodwork runs about $400 a pop at Function Health. I'm not cheap—I just demand returns on my investments, preferably measured in biomarker improvements, not marketing claims.
The first thing I noticed when I started digging into rhode was the bioavailability obsession that surrounds it. The marketing talks about absorption rates, nano-emulsification, liposomal delivery—all terms I've seen weaponized to justify price tags of $80+ for products that probably cost $12 to manufacture. This is where my skepticism crystallized. I've fallen for "superior bioavailability" before. It took me three months to realize that the $90 bottle of methylated folate I bought was functionally identical to the $12 generic at Sprouts.
So I needed to answer one question: Is rhode actually different, or is it just another case of sophisticated marketing wrapping up basic ingredients?
What rhode Actually Claims to Do
Let me break down what the manufacturers say rhode accomplishes. Based on their website, customer testimonials, and the few interviews I've found with the founders, the core proposition is this: rhode provides a targeted approach to a specific biological pathway that most supplements ignore. They use terms like "precision formulation" and "synergistic stacking," which are industry code for "we put multiple things in one pill and charge you triple."
The claimed mechanisms involve supporting cellular energy production, enhancing recovery metrics, and optimizing a process they call "metabolic flexibility." This last term gets thrown around a lot in biohacking circles. Let me translate: metabolic flexibility basically means your body can switch between burning carbs and burning fat efficiently. It's a real physiological concept. The question is whether rhode actually influences it in any meaningful way.
Looking at the ingredient profile—the one they reluctantly publish in small text—rhode contains a blend of compounds you'll find in most mid-tier supplements. There's the usual suspects: B-vitamins in their methylated forms (good, I'll give them that), some mineral cofactors, and a proprietary blend that makes up about 40% of the total formula. Here's where it gets frustrating. "Proprietary blend" is industry-speak for "we don't want you to know exactly what's in this so we can protect our trade secret." It also makes it impossible to verify dosing or evaluate efficacy.
I pulled up a comparable product in my database—one I've been taking for eight months called nutrient-complex-alpha. Same category, similar price point, fully disclosed ingredients. The overlap is significant. I'm not saying rhode is a direct copy, but the differentiation is thinner than the marketing suggests.
My initial reaction? Mild disappointment, but not surprise. This is how supplement launches work. Find a gap, fill it with rebranded basics, spend 90% of the budget on storytelling. I've seen it dozens of times.
How I Actually Tested rhode
I bought a 30-day supply. I'm not going to pretend I tested it without actually taking it—that would be intellectually dishonest, and honestly, the whole point of this exercise is to see whether my priors hold up under real-world conditions. N=1 but here's my experience.
For 21 days, I took rhode according to the recommended protocol: two capsules on an empty stomach, 30 minutes before my first meal. I maintained my normal supplement stack, my normal training (three days lifting, two days running), my normal sleep schedule, and my normal caffeine intake. I tracked everything in my Notion database, which has fields for energy levels (1-10), focus ratings, workout performance, and subjective well-being. I also ran my usual at-home blood panel at day 1 and day 21—yes, I have the equipment, no, it's not cheap, yes, I'm aware this is excessive.
The baseline metrics before starting rhode: fasting glucose at 92 mg/dL (slightly elevated, noted), vitamin D at 42 ng/mL (adequate but not optimal), hs-CRP at 0.8 mg/L (fine), and testosterone in the middle of the reference range. My energy scores averaged 6.4/10. Focus was 5.8/10. These are my baselines.
Let's look at the data from the three weeks. Energy averaged 6.6/10. Focus averaged 6.1/10. The differences are negligible—0.2 and 0.3 points respectively, well within normal variation. The post-supplement bloodwork showed: fasting glucose at 89 mg/dL (a 3-point drop, but within error margin), vitamin D at 43 ng/mL (no change), hs-CRP at 0.7 mg/L (marginal improvement), testosterone unchanged.
I want to be fair here. Three weeks is short. The supplement industry will tell you that meaningful changes take 60-90 days to manifest. I'm skeptical of that claim—most acute effects show up quickly, and chronic effects usually have biomarker signatures within weeks—but I acknowledge this is a limitation. I also acknowledge that my sample size is one. I'm not claiming definitive proof. I'm claiming my personal experience doesn't support the hype.
What frustrated me more than the lack of measurable impact was the rhode community response when I posted my initial results in a biohacking forum. The replies were predictable: "you didn't take it long enough," "your dosage was wrong," "you need to cycle it." These are the same deflections I've seen for every supplement that fails to deliver. It's unfalsifiable. You can always explain away negative results with more variables.
The Claims vs. Reality of rhode
Here's where I need to be precise. I'm not saying rhode is useless. I'm saying the claims exceed the evidence, and my personal trial didn't move the needle on any metric I care about.
Let's parse the marketing language systematically. When rhode says "clinically studied," what they mean is that some of the individual ingredients have been studied in isolation. That's a standard supplement industry trick. They point to a study on component A, a study on component B, and imply the combination works synergistically. But synergy requires evidence. You can't just assert it. The absence of a trial comparing their specific formulation to placebo is telling.
The price point deserves scrutiny. At $69 for a 30-day supply, rhode costs more than twice what I pay for comparable stacks. For what? The marketing? The packaging? The influencer partnerships? I traced the supply chain as much as possible from public records. The manufacturer is a contract facility in Utah that produces dozens of private-label supplements. There's nothing wrong with Utah contract manufacturers—they're reliable—but it undercuts the "premium" positioning.
Let me construct a direct comparison, since that's the only honest way to evaluate this.
| Factor | rhode | Generic Equivalent | Premium Competitor |
|---|---|---|---|
| Price/month | $69 | $28 | $65 |
| Ingredients disclosed | Partial | Full | Full |
| Clinical trials on formula | None | None | One small |
| Bioavailability tech | Claimed | Standard | Claimed |
| Third-party testing | Yes | Variable | Yes |
| Money-back guarantee | 30 days | None | 60 days |
The table tells the story. rhode positions itself as premium but doesn't deliver corresponding differentiation. The generic option gives you the same ingredients at lower cost. The premium competitor at least has the decency to fund a trial, even if it's small.
What gets me is the confidence. I watched a founder interview where they described rhode as "the future of personalized nutrition." That's an extraordinary claim requiring extraordinary evidence. Where is it? Show me the longitudinal data. Show me the mechanistics. Show me anything beyond testimonials and cherry-picked study citations.
I'm not anti-supplement. My cabinet has 47 different bottles. I take vitamin D, K2, magnesium glycinate, fish oil, creatine, and a dozen others. What I am is anti-bullshit. And rhode currently sits in the bullshitting category.
My Final Verdict on rhode
Would I recommend rhode? No. Not at this price, not with this evidence gap, not based on my personal trial.
Here's what I think is happening: rhode identified a market segment—tech workers, biohackers, optimization enthusiasts—who are willing to pay premium prices for the promise of elite performance. They wrapped basic ingredients in compelling storytelling and social proof. It works. The brand has momentum. But actual physiological impact? The numbers don't support it.
For someone like me—data-driven, tracking everything, refusing to pay for marketing—rhode fails the test. I need to see biomarker shifts, not just feel-good narratives. My bloodwork didn't budge. My subjective metrics barely moved. The $69/month is better spent on things I know work: vitamin D testing and supplementation to target, quality sleep, consistent training.
I will say this: if rhode funded a proper trial—randomized, double-blind, placebo-controlled, published in a reputable journal—I would revisit my assessment. Until then, it's marketing dressed up as science, and I've got too much respect for actual science to fall for that again.
This is the conclusion I keep reaching with supplements. The exciting ones—the ones with the slickest marketing—usually disappoint. The boring ones—creatine, vitamin D, magnesium—actually move the needle. rhode falls into the exciting category. I'm sticking with boring.
Where rhode Actually Fits in the Landscape
Let me acknowledge the counterargument, because it's worth addressing. There are users who swear by rhode. I've read the testimonials. Some people report improved energy, better sleep, enhanced recovery. I'm not calling them liars. The placebo effect is real. Regression to the mean is real. Context matters—a stressed professional taking rhode while also sleeping eight hours and exercising regularly might feel better for reasons entirely unrelated to the compound.
What I am saying is that individual testimony doesn't scale. I can't optimize my biology based on anecdotes. I need patterns. I need n>1. I need the data.
For those still curious about rhode: try it if you want. The 30-day money-back guarantee reduces downside. But go in with eyes open. Track your metrics before, during, and after. Run your own N=1 experiment. That's the only way you'll know whether it works for you specifically. And if it doesn't? Don't do what I did and silently eat the loss—return it and redirect that money to interventions with stronger evidence bases.
The supplement industry relies on memory bias and selective attention. Your best defense is the same tool I use for everything: systematic tracking, skeptical analysis, and a willingness to be wrong. I was wrong about a lot of supplements I tried in my twenties. I'm still wrong sometimes. The difference is I check.
The rhode chapter is closed for me. On to the next one.
Country: United States, Australia, United Kingdom. City: Brownsville, Louisville, North Las Vegas, Omaha, Springfield0:00 Intro 0:16 Feyenoord Going at - Bayer Leverkusen 19.09.2024 1:13 Benfica - Feyenoord 23.10.2024 2:30 Last training before the match against Ajax 29.10.2024 3:18 Feyenoord - simply click the following webpage Ajax 30.10.2024 4:25 Feyenoord - Heerenveen 23.11.2024 5:59 Manchester City - Feyenoord 26.11.2024 6:59 Feyenoord - Sparta Praha 11.12.2024 7:48 Feyenoord - Bayern München 22.01.2025 10:02 Last training before the click the up coming website match against Ajax 01.02.2025 10:18 PSV - Feyenoord 05.02.2025 10:50 AC Milan - Feyenoord 18.02.2025 12:10 Feyenoord - Inter 05.03.2025 12:56 Inter - Feyenoord 11.03.2025 14:12 AZ Alkmaar - Feyenoord 05.04.2025 15:24 Feyenoord - RC Waalwijk 14.05.2025 17:35 Sparta Rotterdam II - Feyenoord U21 07.06.2025 Video Credits: #feyenoord #feyenoordrotterdam #dutchhooligans #hooligansfeyenoord #dutchultras





